Search results for: Generics
Filter search results
Fishing for Innovative Drugs with the ODRS: Potential Benefits and Challenges
6 February 2023
…drugs at prices close to those of generics, facilitating greater patient access and placing less strain on budgets. Additional reward payments would then be made over the course of a…
EU Approval of Biosimilars
8 July 2010
…insulin and an interferon-alpha). Experience with biosimilars, then, still is limited. The data required for approval of a biosimilar are different than for small-molecule generics. This is because the biosimilar and the reference…
The Market for Biosimilars: Evolution and Policy Options
1 November 2008
…differences mean that biosimilar markets will evolve in a more complex way than traditional, small molecule, chemical generics markets. Regulators will need clinical trial evidence of efficacy and safety before…
What do Pharmaceuticals Really Cost in the Long Run?
6 October 2017
…the average market price in the year generics entered the market the price was 6% lower than the LOE price. After 5 years it was 55% lower and after 10…
Future UK Medicines Spending: Four Nation Analysis
31 October 2012
…and generics) were divided into primary care and secondary care markets. 2. For each market, we calculated sales for each of the four nations for 2011. 3. To project sales…
Just Released: Health and the Use of Medicines in Wales
3 November 2011
…than elsewhere in the UK. This is explained in large part by a more rapid increase in Wales in prescribing of lower cost medicines, including generics. The report also shows…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…by volume in high-income countries) are off-patent multi-source generics (and, in the future biosimilars). Advice on the effective procurement of these products is key. Acknowledge that R&D is best incentivised…
Antibacterials: Roundtable Addresses the Critical Issues
10 November 2011
…raised included the danger of stewardship being a screen for anticompetitive behavior, the need to include generics, and the possibility of a tax on newly-generic antibiotics to raise funds for…
Health and the Use of Medicines in Primary Care in Wales
1 November 2011
…than elsewhere in the UK. This is explained in large part by a more rapid increase in Wales in prescribing of lower cost medicines, including generics. The report also shows…